MA (EU) number 
(Invented) 
name 
Strength 
Pharmaceutical 
Form 
Route of 
Administration 
Immediate 
Packaging 
Content 
(concentration) 
Pack size 
EU/1/20/1447/001 
EU/1/20/1447/002 
EU/1/20/1447/003 
EU/1/20/1447/004 
EU/1/20/1447/005 
EU/1/20/1447/006 
EU/1/20/1447/007 
Insulin aspart 
Sanofi   
Insulin aspart 
Sanofi   
Insulin aspart 
Sanofi   
Insulin aspart 
Sanofi   
Insulin aspart 
Sanofi   
Insulin aspart 
Sanofi   
Insulin aspart 
Sanofi   
100 U/ml 
100 U/ml 
100 U/ml 
100 U/ml 
100 U/ml 
100 U/ml 
100 U/ml 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Solution for 
injection 
Subcutaneous use 
Subcutaneous use 
Subcutaneous use 
Subcutaneous use 
3 ml (3.5 mg/ml) 
3 ml (3.5 mg/ml) 
cartridge (glass) 
in pre-filled pen 
(SoloStar) 
cartridge (glass) 
in pre-filled pen 
(SoloStar) 
cartridge (glass) 
in pre-filled pen 
(SoloStar) 
cartridge (glass)  3 ml (3.5 mg/ml) 
3 ml (3.5 mg/ml) 
1 pre-filled pen  
5 pre-filled pens  
10 pre-filled pens  
5 cartridges  
Subcutaneous use 
cartridge (glass)  3 ml (3.5 mg/ml) 
10 cartridges  
Intravenous use, 
Subcutaneous use 
Intravenous use, 
Subcutaneous use 
Vial (glass)  
10 ml (3.5 mg/ml)  1 vial  
Vial (glass)  
10 ml (3.5 mg/ml)  5 vials  
 
 
 
 
 
 
